Clinic

Die vermehrte Ablagerung von Bindegewebe ist ein Problem bei chronischen Erkrankungen vieler Organe. Effektive Behandlungsmöglichkeiten stehen derzeit kaum zur Verfügung. Wissenschaftler aus der Medizinischen Klinik 3 haben jetzt ein molekulares Netzwerk entschlüsselt, das diese Prozesse kontrolliert und dadurch eine neue Möglichkeit für die Therapie von Organvernarbung darstellen könnte.

There is a strong link between depression and anxiety disorders and autoimmune thyroiditis (AIT), a chronic thyroid disease affecting approximately 10 percent of the population. Special treatment could help a lot of sufferers – especially women.

The Department of Medicine 4 is a member of a worldwide consortium that has the aim of improving treatment of chronic kidney disease.

Researchers at the Department of Neurology demonstrated the significant influence of new signal paths of the renin-angiotensin system (RAS).

The patient perspective is important in all medical research, and particularly in drug development. This is reflected in the European research initiative PREFER in which a research group at the Department of Medicine 3 is involved.

A study shows a new, surprising role played by blood vessels: under certain conditions they can inhibit tumor growth.

Around 400,000 people in Germany suffer from chronic inflammatory bowel disease. Researchers at the Faculty of Medicine have recently published findings showing that a special technique can improve the examination procedure for the disease.

About 80% of deaths caused by chronic, non-communicable diseases occur in low or middle income countries. Patients are often uninformed about causes and treatment options, which can lead not only to a deterioration in their state of health, but also to social exclusion. Improving health education and patient-oriented care offer considerable opportunities for prevention and treatment of chronic diseases.

A research team at the Department of Medicine 3 has discovered a mechanism that stops chronic inflammation.

How likely do patients develop again cancer after a tumor has been surgically removed? This is the central question of the new research project „MelEVIR – Melanoma, Extracellular Vesicles, and Immune Response“.